Susquehanna International Group
FLGT icon

Susquehanna International Group’s Fulgent Genetics FLGT Stock Holding History

Susquehanna International Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$778K Sell
48,900
-2,600
-5% -$56.4K ﹤0.01% 8541
2025
Q4 		$1.35M Buy
51,500
+26,900
+109% +$698K ﹤0.01% 6490
2025
Q3 		$556K Sell
24,600
-300
-1% -$6.18K ﹤0.01% 8712
2025
Q2 		$495K Buy
24,900
+8,400
+51% +$164K ﹤0.01% 9199
2025
Q1 		$279K Buy
+16,500
New +$281K ﹤0.01% 10222
2024
Q3 		– Sell
-15,200
Closed -$298K – 12290
2024
Q2 		$298K Sell
15,200
-22,500
-60% -$470K ﹤0.01% 9463
2024
Q1 		$818K Sell
37,700
-21,100
-36% -$524K ﹤0.01% 7364
2023
Q4 		$1.7M Sell
58,800
-230,700
-80% -$6.17M ﹤0.01% 5705
2023
Q3 		$7.74M Buy
289,500
+248,600
+608% +$8.49M ﹤0.01% 2887
2023
Q2 		$1.51M Sell
40,900
-37,200
-48% -$1.3M ﹤0.01% 5746
2023
Q1 		$2.44M Sell
78,100
-39,300
-33% -$1.26M ﹤0.01% 4739
2022
Q4 		$3.5M Sell
117,400
-51,600
-31% -$1.85M ﹤0.01% 3775
2022
Q3 		$6.44M Sell
169,000
-174,900
-51% -$8.77M ﹤0.01% 2774
2022
Q2 		$18.8M Buy
343,900
+101,800
+42% +$5.59M ﹤0.01% 1504
2022
Q1 		$15.1M Buy
242,100
+92,300
+62% +$6.08M ﹤0.01% 2020
2021
Q4 		$15.1M Sell
149,800
-106,000
-41% -$9.32M ﹤0.01% 2170
2021
Q3 		$23M Sell
255,800
-38,400
-13% -$3.49M ﹤0.01% 1832
2021
Q2 		$27.1M Buy
294,200
+31,900
+12% +$2.55M ﹤0.01% 1708
2021
Q1 		$25.3M Buy
262,300
+152,000
+138% +$15.7M ﹤0.01% 1624
2020
Q4 		$5.75M Buy
110,300
+28,700
+35% +$1.2M ﹤0.01% 3210
2020
Q3 		$3.27M Buy
+81,600
New +$2.55M ﹤0.01% 3715

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's FLGT Position: Q1 2026 in Review

Susquehanna International Group increased its Fulgent Genetics (FLGT) stake by 254% in Q1 2026, buying an estimated $593K and bringing the position to 38,078 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #9169.

Susquehanna International Group first reported a position in FLGT in Q1 2018 and has held it in 25 quarters since. The position peaked at $15.2M in Q2 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Susquehanna International Group held 38,078 shares of Fulgent Genetics worth $605K as of Q1 2026.
  • Susquehanna International Group bought 27,310 Fulgent Genetics shares in Q1 2026, an estimated $593K.
  • Fulgent Genetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9169 holding.
  • Susquehanna International Group first reported a position in Fulgent Genetics in Q1 2018 and has held it in 25 quarters since.
  • Susquehanna International Group's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.